Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Drug crawled date : 2021 - 11 - 08 save search
Ocugen, Inc. Announces Submission of Investigational New Drug Application with U.S. FDA to Initiate a Phase 1/2 Clinical Trial Evaluating Gene Therapy Candidate OCU400
Published: 2021-11-08 (Crawled : 18:00) - biospace.com/
OCGN | News A | $1.315 -0.38% -0.38% 6.5M
|
Health Technology
|
| O: 0.4%
H: 1.16%
C: -6.33%
new drug fda application phase 1 gene therapy therapy drug trial submission
Global Baby Cleanser & Body Wash Market (2021 to 2026) - Featuring Johnson & Johnson, The Hain Celestial and The Himalaya Drug Company Among Others
Published: 2021-11-08 (Crawled : 15:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.61%
H: 0.0%
C: 0.0%
HAIN | $5.995 1.78% 1.67% 1.8M
|
Consumer Non-Durables
|
| O: 0.2%
H: 0.09%
C: -0.3%
drug
Seelos Therapeutics Announces FDA Acceptance of Investigational New Drug Application and Grant of Fast Track Designation for SLS-005 (IV Trehalose) for the Treatment of Spinocerebellar Ataxia
Published: 2021-11-08 (Crawled : 15:15) - biospace.com/
SEEL | $0.3502 3.61% 3.48% 290K
|
Health Technology
|
| O: 0.9%
H: 4.04%
C: 2.69%
new drug fast track designation treatment fda fda acceptance application fast track drug designation
Ocugen, Inc. Announces Submission of Investigational New Drug Application with U.S. FDA to Initiate a Phase 1/2 Clinical Trial Evaluating Gene Therapy Candidate OCU400 (AAV-NR2E3) to Treat Inherited Retinal Degeneration
Published: 2021-11-08 (Crawled : 15:00) - globenewswire.com
OCGN | News A | $1.315 -0.38% -0.38% 6.5M
|
Health Technology
|
| O: 0.4%
H: 1.16%
C: -6.33%
new drug fda application phase 1 gene therapy therapy retina drug trial submission
Hoth Therapeutics Inks API and Drug Product Contracts with WuXi STA to Advance Manufacturing of HT-KIT Cancer Therapeutic
Published: 2021-11-08 (Crawled : 13:15) - ir.hoththerapeutics.com
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: -0.91%
H: 3.67%
C: 1.83%
cancer contract drug
Genetron Health Establishes Strategic Partnership with NeoGenomics to Drive Global Oncology Drug Research and Development
Published: 2021-11-08 (Crawled : 11:00) - globenewswire.com
NEO | $13.54 -1.67% -1.7% 770K
|
Health Services
|
| O: 7.22%
H: 7.81%
C: 6.79%
partnership genomics genomic drug research
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.